The effects of certain hypocholesterolemic agents on hepatic delta-aminolevulinic acid synthetase levels in mice.
D000624:5-Aminolevulinate Synthetase / Q000096:biosynthesis*; D000475:Alkenes / Q000494:pharmacology; D000502:Allylisopropylacetamide / Q000037:antagonists & inhibitors; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001593:Benzyl Compounds / Q000494:pharmacology; D002087:Butyrates / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood; D003510:Cyclohexanes / Q000494:pharmacology*; D003864:Depression, Chemical; D004790:Enzyme Induction / Q000187:drug effects; D005019:Ethyl Ethers / Q000037:antagonists & inhibitors; D005260:Female; D008744:Methylamines / Q000494:pharmacology; D051379:Mice; D008930:Mitochondria, Liver / Q000201:enzymology*; D011164:Porphyrias / Q000139:chemically induced; D011725:Pyridines / Q000037:antagonists & inhibitors
D000475:Alkenes; D000924:Anticholesteremic Agents; D001593:Benzyl Compounds; D002087:Butyrates; D003510:Cyclohexanes; D005019:Ethyl Ethers; D008744:Methylamines; D011725:Pyridines; D000502:Allylisopropylacetamide; D002784:Cholesterol; D000624:5-Aminolevulinate Synthetase